Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Improved Survival and Prognostication in Melanoma Patients With Brain Metastases: An Update of the Melanoma Graded Prognostic Assessment.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 17, 2025
Repurposing the Antihypertensive Agent Hydralazine As an Inhibitor of the Base Excision Repair Enzyme APE1.
Journal: Chemical research in toxicology
Published: December 24, 2024
Ultrafast Reaction of the Drug Hydralazine with Apurinic/Apyrimidinic Sites in DNA Gives Rise to a Stable Triazolo[3,4-a]phthalazine Adduct.
Journal: Chemical research in toxicology
Published: May 14, 2024
Development of a [89Zr]Zr-labeled Human Antibody using a Novel Phage-displayed Human scFv Library.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 22, 2023
Exploiting Radiation Induction of Antigens in Cancer: Targeted Drug Delivery.
Journal: International journal of molecular sciences
Published: January 05, 2022
Targeting a Radiosensitizing Antibody-Drug Conjugate to a Radiation-Inducible Antigen.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 05, 2020
Interstrand DNA Cross-Links Derived from Reaction of a 2-Aminopurine Residue with an Abasic Site.
Journal: ACS chemical biology
Published: July 02, 2019
Covalent adduct formation between the antihypertensive drug hydralazine and abasic sites in double- and single-stranded DNA.
Journal: Chemical research in toxicology
Published: November 19, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026